Submissions

Login or Register to make a submission.

Author Guidelines

Editorial policies

Dermatology Online Journal (DOJ) is a refereed journal published by Dermsquared.com. Original manuscripts will be considered for publication. Information that has been published or is being considered for publication elsewhere will not be accepted. Manuscripts that appear to meet the goals of the Journal will be reviewed by one or two independent reviewers before a decision is made on publication (Case Reports, Photo Vignettes, and Letters may sometimes be reviewed by one independent reviewer). Authors have the option of submitting their work for blind peer review when uploading their manuscript. This ensures that all identifying Author information is removed from the text before being sent to Reviewers. Otherwise, an open peer review process will be conducted. The Journal charges no fees for submission or reviewing, but a fee may be levied for correction of post-publication errors arising from author omissions during the proofing process. Authors who have a new concept for on-line presentation are invited to contact the Editors to initiate a dialog. Published articles are indexed in, and appear in PubMed, a month after publication.

Please refer to our Policies page for additional information.

Features of Dermatology Online Journal

  • Original Article: Original in-depth clinical or translational research articles
  • Research Letter: Concise reports of original research findings of limited scope that provide novel and timely insights
  • Review Article: Comprehensive, evidence-based syntheses of the current literature on clinically relevant topics in dermatology
  • Case Report / Case Series: Descriptions of single cases or small patient series that provide novel clinical insights, diagnostic lessons, or therapeutic observations
  • Photo Vignette: Exceptionally visually striking dermatological images
  • Consensus Statements and Recommendations: Evidence-informed recommendations developed by expert panels
  • Scholarly Commentary: Provide scholarly analysis, expert interpretation, or critical discussion of important issues relevant to the practice, research, policy, or future direction of dermatology.
  • Forensic Dermatology: Describes dermatologic findings that aid in the interpretation of injury, trauma, environmental exposure, or postmortem skin changes. 

Pre-submission instructions

Before beginning, please read all section requirements outlined below. 

All Case Reports and Photo Vignettes require clinical images and histology images are highly encouraged. If no histology images are available, you must provide a brief explanation as to why in the cover letter. Please be sure that images are not blurry and are large enough to clearly see the condition. Submissions may be rejected without full review for poor quality images. Images should be in good focus and submitted in JPEG or TIFF format of file size approximately 1MB.  Images may include a scale bar. Figures with sub panels must be submitted as individual files clearly labeled and may NOT contain superimposed panel labels (A, B, C, etc.).

See discussion regarding patient consent below. Upload the completed Submission Checklist and check that it is the correct version.

Formatting your article

After ensuring all formatting guidelines relevant to the selected submission category are met, the main article text will be uploaded to the submission portal.

Please ensure that Figures and Tables are submitted as separate files. Please upload these as supplementary files. Figure Legends must be entered at the end of the main submission file (article text).

Transmitting your work to the Journal and copyright information

Once your manuscript is prepared for submission, please follow the submission form at the Submit button above. You will receive an email confirmation once your submission has been successfully submitted.

To assist in preparation of your manuscript download, complete, and submit the correct version (currently: June 2025 version) of the Journal Submission Checklist. The completed and signed Submission Checklist must be uploaded onto our site and labeled as "Submission Checklist".

By submitting your article for publication, you grant Dermsquared the right to publish it and associated images in electronic format (on the Internet or as a CD-ROM version of the Internet site) or in paper format of the digital version in the Dermatology Online Journal. Please refer to the Policies page for detailed copyright information.

Patient Consent

A signed statement of informed consent must be obtained and kept in the possession of the author/institution to publish patient descriptions, photographs, video, medical information, and pedigrees from all persons (parents or legal guardians for minors) who can be identified, even by the individual themselves. Note that blocking the eyes is not acceptable for masking identity.

Please only provide patient details that are essential for the understanding or interpretation of a report. Although the specificity of patient information depends on context, specific ages, race/ethnicity, and other sociodemographic details should rarely be presented. Please do not submit masked photographs of patients. Patients' initials or other personal identifiers must not appear in an image.

Patient consent, obtained on author institutional form, DOJ’s template, or an equivalent, must be held by author/institution. Our DOJ consent form or institutional consent forms that specify consent for publication of images and personal health information may be used. Possession of this consent form must be attested to in the Submission Checklist. The completed and signed Submission Checklist must be uploaded onto our site as a supplemental file.

Submitting Revisions

If revisions are requested, a detailed point-by-point response describing how you have addressed each of the comments of the reviewers and editors, including your reasons for not taking their guidance in cases where you disagree is required. Please submit a "marked (tracked)" copy of the manuscript with the changes highlighted in the revised document. This should be a separate word document that lists all editorial comments/questions, with your response and changes listed underneath each. If revisions are requested for tables or figures, please upload as separate files and clearly label them as "revised Table 1", "revised Fig 1A", etc.

When you are ready, upload the required files to your submission dashboard, including: point-by-point response word document, revised manuscript word document and any figure/table revisions if required. 

Accepted Articles

Upon acceptance of your work, all final figures, tables, and/or media with corresponding legends should be compiled into a final word document to be submitted to the DOJ website. This document must contain the final versions of all materials (including supplementary figures) that will be used in the publication of your manuscript.

Style

Manuscripts should conform to acceptable English language usage. Abbreviations must be used minimally and be limited primarily to those in general usage and must be identified when first used. Generic drug names must be used. If a trade name is included, it should follow the generic name in parentheses the first time mentioned. Thereafter, only generic names should be used. Weights and measurements should be expressed in metric units and temperatures in degrees centigrade. Patient descriptions, as in case reports, should not contain identifying information.

We discourage sentences that begin with most abbreviations, initializations, and numbers/symbols. For example, following the first time Lichen planus is used in an article, it can be placed in parentheses (LP) so that LP is used in the remainder of the article. However, when there is a sentence that begins with the phrase it should be written out as Lichen planus and not LP.

The Editors encourage the use of more than one pathway of presentation of the material which might allow the reader greater flexibility in viewing. Items may link back to the primary manuscript path or link to additional supplemental content.

Images and tables

Images/Figures and Tables must be submitted separately from the manuscript and submitted as individual files. Please label files appropriately (i.e. Figure 1, Table 1). Figures and/or Tables must be referenced within the main text, and must be accompanied by figure legends or table titles.

The use of images is required for some Article Categories (please see above in Pre-Submission Instructions). Manuscripts must include in-text references to Figures and Tables; Authors may indicate the appropriate location of the figures within the text. Clinical photographs should be saved in JPEG compression format. The minimal accepted size for images is 1024*768 pixels, and image files should be about 1 MB in size. Larger files are difficult to handle for Reviewers, particularly when several images are present, and will delay review and processing. The journal edits the images to arrange them in-line with text; accordingly, do not include text labeling of subpanels (e.g., 'A,' 'B,' etc) in a figure montage.

Possession of signed consent of subjects must be attested to in the Submission Checklist. Identifying personal features, such as jewelry or tattoos, must be cropped or obscured from photographs. No photographs with identifiable features will be published unless there is a specific need, AND permission has been granted in writing for this use and may be requested by journal editors.

Tables should be submitted separately as a Word text document in Table format and not as an image.

Human and animal rights

Any work involving the use of human subjects or animals requires formal review by a institutional review board or ethics committee. This should be detailed in the Methods section.

Conflicts of interest

All Authors must disclose any financial or personal affiliations or relationships with individuals or organizations that could potentially influence (bias) the Authors' work/manuscript. Examples include employment, consultant positions, stock ownership, honoraria, expert testimony, patents, grants or other funding sources. Please include this statement in the Title Page.

References

Please refer to our specifications below for formatting of references. Although we had offered a plugin in the past for one reference manager we are unable to endorse any specific utility program. It is the responsibility of authors to format their reference lists appropriately because manuscripts with inappropriate reference formatting will not be processed for publication.

Authors are responsible for the accuracy of citations. Reference citations within the article should be in numerical order and noted with superscripts after punctuation. 3,4,6 or 1-3 If necessary one may also place a citation in the middle of a sentence (The sentence may need to pinpoint the citation to a specific comment 5 and not link it to the subsequent remarks). The same format should be applied to Tables and Figure/Table legends.

In the Reference section, list the references in the order of citation appearing within the text and by a simple number at the start of a line followed by a period. Citations with more than 5 Authors/Editors should list the first 3 followed by 'et al.' Use the citation format of PubMed, including the PMID number, DOI number but no issue numbers in parentheses:

Example References:

Five Authors, or less:
1. Lacouture ME, Patel AB, Rosenberg JE, O’Donnell PH. Management of dermatologic events
associated with the nectin-4-directed antibody-drug conjugate enfortumab vedotin. Oncologist.
2022;27:e223-32. doi:10.1093/oncolo/oyac001. [PMID:35274723]
More than five Authors:
5. Challita-Eid PM, Satpayev D, Yang P, et al. Enfortumab vedotin antibody-drug conjugate targeting nectin-4 is a highly potent therapeutic agent in multiple preclinical cancer models. Cancer Res. 2016;76:3003-3013. doi:10.1158/0008-5472.CAN-15-1313. [PMID:27013195]

Book:
4. Lee C, Koo J. Psychocutaneous Diseases. In: Dermatology. Bolognia J, Jorizzo J, Schaffer J, editors. 3rd ed. Elsevier Limited; 2012. p. 127-34.

Web link:

5. Howlader N, Noone AM, Krapcho M, et al. (eds). SEER Cancer Statistics Review, 1975-2009 (Vintage 2009 Populations). 2012. http://seer.cancer.gov/csr/1975_2009_pops09/. Accessed on April 1, 2001.

Errata and corrigenda

Contact the Editors early for corrections to submitted manuscripts. The Corresponding Author(s) accepts responsibility for accuracy of all content in submitted articles. Any changes post publication may be made to manuscripts at the Editor's discretion. Corrections in names, affiliations, contact information, or article contents after publication may incur processing charges.

Image Requests for republication of images/text/tables

  1. For any requests to re-use images from DOJ, fill out the image request form found here.
  2. Once the request form is filled out, please email the completed request form and relevant images to the Journal email (doj@dermsquared.com).
  3. Please attach your requested images along with the form.

Submission Preparation Checklist

Cover letter

  • Title of manuscript, brief description, and importance to dermatologic literature
  • Clarify any conflicts of interest

Manuscript/Submission file

  • Submission must be written in proper United States English
  • The manuscript or case must be unpublished, and not under consideration at another journal (or an explanation must be provided in ‘Comments to the Editor’ section)
  • Select appropriate article type and format accordingly from the Dermatology Online Journal website
  • Authors list should include degrees and affiliations. Example: Jane Doe1 MD,… 1Department of Dermatology, University of California, Davis Medical Center, Sacramento, CA, USA
  • Provide full contact information for Corresponding Author(s); this author should provide a long-term contact email
  • Include Figure and Table legends after References in the manuscript/submission file
  • All tables and figures must be referenced in the paper. Example: This was consistent with the diagnosis (Figure 1C)
  • Generic drug names must be used, not trade names
  • Use appropriate units: weight measurements in metric units and temperature in centigrade. Include normal ranges
  • Minimize abbreviations and do not begin a sentence with an abbreviation or a numeral. Spell out abbreviations when first used. 
  • Patient descriptions must not contain identifying information
  • Upload submission file in Microsoft Word (‘.docx’) format

References

  • Referenced citations within the article should appear in numerical order and be noted with superscripts after punctuation. Example: 2,3,6 or last word of sentence. 1-3
  • In the Reference section, list references by a simple number at the start of a line, followed by a tab mark. Carefully observe examples on the DOJ submission site. Please list references in order of in-text citations

Tables

  • Include tables in a separate Word document, and label file with table name. e.g., Table 1
  • Tables should be no larger than 150KB and limited to no more than 2 (two) pages

Figures

  • Include Figures as separate JPG or TIFF files (about 1MB) and label file with image name. e.g., Figure 1A
  • Attached image files in sequential order as cited in manuscript. Composite photos should be uploaded as separate image files without A,B,C on the image.
  • Case Reports and Photo Vignettes require both clinical and histologic images
  • Photographs and histologic images should be of high quality. Suggested resolution is 150 dpi, a minimum of 1024*768 pixels, and size about 1MB.
  • Do NOT add any superimposed labels (e.g., A, B, C,…) on image montages; these will be inserted at publication
  • Reuse of published figures and tables must be accompanied by written permission from the publisher

Supporting information

  • All listed authors must have read, and approved submission of the manuscript
  • Signed patient consent for publication of images and patient medical information must be possessed by author and attested to by submission and in Submission Checklist. 
  • Statement of approval from Institutional Review Board, if appropriate
  • All changes post acceptance must be performed during the final author acknowledgement of the manuscript and accompanying information.  Corrections post-publication are at the Editor’s discretion; a fee may be charged
  • Authors agree with Copyright statement/Author Publication agreement as found in Author Guidelines: Dermatology Online Journal website

Original Article

Original Article: Original in-depth clinical or translational research articles.

Submissions may include original clinical trials, observational studies, epidemiological investigations, post-hoc analyses of clinical trial, or translational studies that advance understanding of dermatologic disease, therapeutics, or mechanisms. Authors must adhere to established reporting guidelines, particularly CONSORT for randomized clinical trials and STROBE for observational and epidemiologic studies, as applicable.

Word Count: 1,500–3,000 words (excluding abstract, references, tables, and figure legends)

Abstract: A structured abstract of up to 300 words that includes the following sections: Background; Objective; Methods; Results; Conclusion.

Highlights: A two-sentence summary (<60 words), paragraph format. First sentence should describe the key novel/ unique findings. Second sentence should describe clinical implications.

Manuscript Structure for Original Articles:
Manuscripts should be organized into the following sections:

  • Introduction
  • Methods
  • Results
  • Discussion
  • Conclusion

Figures: Maximum 6
Tables: Maximum 6

References: Maximum 50

Research Letter

Research Letter: Concise reports of original research findings of limited scope that provide novel and timely insights

Research Letters provide a concise format for reporting original research findings that are of clear relevance to the practice, science, or epidemiology of dermatology but are more limited in scope than full Original Articles. Appropriate submissions may include concise reporting of clinical trials or observational studies, focused analyses of datasets, brief epidemiologic investigations, or early translational observations.

Research Letters should present novel data and clearly described methods, allowing readers to understand how the analysis was conducted and how the conclusions were derived.

Authors should adhere to appropriate reporting standards depending on study design, including the CONSORT Statement for randomized clinical trials and the STROBE Statement for observational or epidemiologic studies, as applicable.

Case-based letters or single case descriptions will not be considered under this category.

Word Count: Maximum 1,500 words (excluding abstract, references, tables, and figure legends)

Abstract: A structured abstract of up to 300 words that includes the following sections: Background; Objective; Methods; Results; Conclusion.

Highlights: A two-sentence summary (<60 words), paragraph format. First sentence should describe the key novel/ unique findings. Second sentence should describe clinical implications.

Manuscript Structure for Research Letters

Research Letters should be concise but include sufficient methodological detail. Suggested sections include:

  • Introduction
  • Methods
  • Results
  • Discussion / Conclusion

Figures: Maximum 4

Tables: Maximum 4

References: Maximum 15

Review Article

Review Article: Comprehensive, evidence-based syntheses of the current literature on clinically relevant topics in dermatology

In-depth, up-to-date literature reviews and discussions on topics relevant to the teaching and clinical practice of dermatology. The journal particularly welcomes high-quality systematic reviews, including systematic reviews with meta-analysis, that provide a rigorous and transparent synthesis of the available evidence.

Systematic reviews should adhere to established reporting standards such as the PRISMA Statement. Authors are encouraged to submit the appropriate checklist and flow diagram when applicable.

Submission of narrative and scoping reviews are generally discouraged due to limited journal space and the substantial number of such articles already available in the dermatology literature. These article types will be considered only in exceptional circumstances, such as when the topic is of high clinical importance to a broad dermatology audience and when recent high-quality reviews on the same topic have not already been published elsewhere. Narrative or scoping reviews must clearly and transparently describe the methodology used for identifying and selecting articles, including the databases searched, search terms, time frame, and inclusion/exclusion criteria. Submissions that lack a clear and reproducible article selection methodology are unlikely to be considered for review.

For narrative and scoping reviews, in the cover letter, authors must also disclose whether artificial intelligence (AI) tools were used at any stage of the writing, literature synthesis, or manuscript preparation process, and specify the tools used and the nature of their contribution.

Articles should be well illustrated where appropriate to enhance clarity and educational value.

Word Count: 1,500–3,500 words (excluding abstract, references, tables, and figure legends)

Abstract: A structured abstract of up to 300 words that includes the following sections: Background; Objective; Methods; Results; Conclusion.

Highlights: A two-sentence summary (<60 words), paragraph format. First sentence should describe the key novel/ unique findings. Second sentence should describe clinical implications.

Manuscript Structure for Review Articles:

  • Introduction (context and rationale for the review)
  • Methods (literature search strategy, databases searched, inclusion/exclusion criteria, and study selection process)
  • Results (Evidence Synthesis)
  • Discussion (interpretation of findings, clinical implications, limitations)
  • Conclusion

Figures: Maximum 5
Tables: Maximum 5 

References: Maximum 50

Case Report / Case Series

Case Report / Case Series: Descriptions of single cases or small patient series that provide novel clinical insights, diagnostic lessons, or therapeutic observations.

Case Reports and Case Series describe single cases or small series of patients that provide novel clinical insight, diagnostic learning, or therapeutic observations relevant to dermatology.

Submissions should present new clinical observations, instructive diagnostic dilemmas, novel off-label use of therapies, or unexpected treatment responses where the relationship to therapy is supported by clinical evidence rather than temporal association alone. Manuscripts should go beyond simply describing uncommon or rare conditions. Reports that present cases without clear distinction from previously published descriptions are unlikely to be considered. All submissions must begin with a brief statement (approximately 50 words) explaining why the case or case series is unique or novel and how it advances understanding of dermatologic disease, diagnosis, or management.

High-quality images are strongly emphasized. Submissions should include clear, high-resolution clinical photographs, and histopathologic images are strongly encouraged when relevant to diagnosis or disease characterization. For diagnostic dilemmas or teaching cases, the journal particularly values submissions that include both clinical and pathologic correlation when possible.

A robust discussion is expected, placing the case in the context of the existing literature and clearly highlighting its novelty, clinical relevance, and implications for dermatology practice or understanding of disease.

Word Count: 600–1,200 words (excluding references, tables, and figure legends)

Abstract: Not permitted

Highlights: A two-sentence summary (<60 words), paragraph format. First sentence should describe the key novel/ unique findings. Second sentence should describe clinical implications.

Manuscript Structure for Case Reports and Case Series

Authors may structure manuscripts differently depending on whether the submission is a single case report or a case series, but all manuscripts must include the “Highlights” section at the beginning as described above.

Structure for Case Report (Single Patient) or Case Series (Multiple Patients)

  • Introduction (brief context and rationale for reporting the case or case series)
  • Case Presentation / Case Summaries – Detailed description of the patient (or patients) including demographics, relevant medical history, clinical presentation, examination findings, diagnostic evaluation, treatment, and clinical course.
  • Discussion – Clinical interpretation of the case or case series including differential diagnosis, comparison with existing literature, explanation of what makes the case novel or educational, and implications for dermatology practice.

Figures: Maximum 8

High-quality clinical photographs are strongly encouraged, and inclusion of histopathologic images is preferred when applicable. Images should be clear, well-labeled, and directly relevant to the clinical findings.

Tables: Maximum 2

Tables may be used to summarize clinical characteristics of patients, diagnostic findings, or comparisons with previously reported cases, particularly for case series.

References: Maximum 5

Photo Vignette

Photo Vignette: Exceptionally visually striking dermatological images

Photo Vignettes present exceptionally visually striking dermatologic images that communicate a clear clinical or morphologic teaching point. Submissions should feature high-quality photographs that highlight distinctive dermatologic findings or unusual presentations in which the visual features of the case are central to understanding the diagnosis or clinical insight.

The accompanying text should be brief and focused, providing only the essential clinical context, diagnosis, and key teaching point. Emphasis should remain on the visual characteristics that make the case noteworthy or educational.

Images must be of sufficient clarity and quality to clearly demonstrate the dermatologic findings.

Word count: Maximum 300 words

Abstract: Not permitted
Figures: Maximum 3
Tables: Not permitted

References: Not permitted

Consensus Statements and Recommendations

Consensus Statements and Recommendations: Evidence-informed recommendations developed by expert panels

Consensus statements, clinical recommendations, and position statements provide evidence-informed recommendations developed by expert panels on topics relevant to the practice, teaching, or policy of dermatology. These articles should synthesize the available evidence and clearly describe the process used to develop consensus recommendations.

Submissions may include clinical practice guidance, expert consensus recommendations, or position statements from professional groups, working groups, or multidisciplinary panels addressing important areas of dermatologic care, emerging therapies, diagnostic approaches, or clinical management strategies.

Manuscripts should follow established guidance for reporting guideline and consensus development where applicable.

Authors must clearly describe the methodology used to develop the consensus, including:

  • Selection of panel members and their expertise
  • Evidence review or literature search methods
  • The process used to develop recommendations (e.g., Delphi process, modified Delphi, nominal group technique, or structured expert consensus)
  • Voting procedures or agreement thresholds used to determine consensus
  • Any grading of evidence or strength of recommendations, if applicable

Consensus statements that do not include a clearly defined methodology for consensus development or evidence review are unlikely to be considered for publication.

Word Count: 2,000–4,000 words (excluding abstract, references, tables, and figure legends)

Abstract: A structured abstract of up to 300 words that includes the following sections: Background; Objective; Methods (including consensus methodology); Consensus Recommendations / Key Findings; Conclusion.

Manuscript Structure for Consensus Statement and Recommendations

  • Introduction (clinical importance and rationale for guidance)
  • Methods (panel selection, literature review, consensus methodology)
  • Evidence Review (summary of available evidence where applicable)
  • Consensus Statements / Recommendations
  • Discussion (clinical implications, limitations, future research needs)
  • Conclusion

Figures: Maximum 5

Tables: Maximum 5

Tables summarizing recommendations, levels of agreement, or strength of evidence are encouraged where appropriate.

References: Maximum 50

Scholarly Commentary

Scholarly Commentary

Scholarly commentary articles provide scholarly analysis, expert interpretation, or critical discussion of important issues relevant to the practice, research, policy, or future direction of dermatology. These manuscripts should offer clear insight, thoughtful critique, or new conceptual perspectives grounded in evidence and clinical experience.

Scholarly commentaries should address topics of broad relevance to the dermatology community, such as interpretation of emerging research findings, implications of new therapeutic developments, evolving clinical paradigms, health policy issues, or methodological considerations in dermatologic research. Submissions should provide balanced, evidence-informed perspectives rather than opinion alone.

Due to limited space and the desire to maintain a high level of scholarly rigor, scholarly commentary submissions are expected to present a clear thesis supported by appropriate references and analysis. Commentaries that primarily express personal opinion without substantive scholarly discussion are unlikely to be considered for publication.

Authorship is limited to a maximum of two authors.

Word Count: 800–1,200 words (excluding references) 

Abstract: Not permitted

Manuscript Structure

  • Introduction (context and rationale for the commentary)
  • Main Argument or Perspective (evidence-informed analysis or interpretation)
  • Implications for Dermatology Practice, Research, or Policy
  • Conclusion

Figures and Tables: Figures or tables should be used only when they meaningfully clarify the argument or summarize key information.

Maximum 1 figure and 1 table.

References: Maximum 7

Forensic Dermatology

Forensic Dermatology

This category includes manuscripts describing dermatologic findings that aid in the interpretation of injury, trauma, environmental exposure, or postmortem skin changes. Submissions should highlight distinctive cutaneous patterns or presentations that provide insight into the origin, timing, or mechanism of skin lesions and offer educational value for dermatologists.

Manuscripts may describe a single case or a series of cases

Word count: Maximum 1,000 words

See Case Report or Case Series description above for specific formatting requirements.

Copyright Notice

Publication Agreement
The Dermatology Online Journal

The Foundation for Research and Education in Dermatology DBA Dermsquared (“Publisher”), publishes The Dermatology Online Journal (“Journal”).  By submitting your work for possible publication, you (“Author/Artist”) agree to this legally binding contract.

  1. GRANT OF RIGHTS.
    1. Author/Artist grants to Publisher transferable, exclusive first rights to publish Submission in any medium.
    2. Author/Artist grants to Publisher transferable, nonexclusive second rights to publish Submission in any medium now known or developed in the future, including digital and electronic.
    3. Author/Artist retains all rights not otherwise transferred in this Agreement, including copyright ownership; however, Author/Artist shall not permit commercial use of Submission without Publisher’s permission.
    4. If Publisher does not publish the Submission within one year of complete submission from all authors and/or artists, this Agreement shall terminate automatically and all rights revert to authors and artists.
  2. AUTHOR/ARTIST’S WARRANTY.
    1. Author/Artist warrants that either s/he is the sole author as defined by US copyright law and that it is entirely his/her original work, except parts taken from the “public domain” or parts used in accordance with “Fair Use” as defined by US copyright law, or that Author/Artist is not the sole author but has obtained written permission (a license) to use anyone else’s copyright-protected material in the Submission. Author/Artist is responsible for paying all fees.  Author/Artist will provide those licenses to Publisher upon request.
      Note:  Each author or artist must complete this form before Submission will be considered for publication.
    2. Author/Artist warrants that s/he has not sold, assigned, leased, licensed or in any manner disposed of or encumbered the rights granted to Publisher, and that s/he has the right to enter into this Agreement.
    3. Author/Artist warrants that the Submission does not infringe any copyrights or trademarks, nor violate any proprietary rights, nor contain any libelous matter, nor invade the privacy of any person or third party.
    4. The Author/Artist agrees to defend, indemnify and hold harmless the Publisher, its affiliates, their agents or employees for any losses, claims, damages, awards, penalties, or injuries incurred, including any reasonable attorney's fees that arise from any breach of warranty or for any claim by any third party of an alleged infringement of copyright or any other intellectual property rights arising from the Author/Artist’s submission of materials to the Publisher, or of the use by the Publisher or Publisher’s affiliate or other users of such materials.
  3. MISCELLANEOUS
    1. ACKNOWLEDGEMENT. Publisher shall credit Author/Artist on any publication of Submission.  In any subsequent license granted by Author/Artist, s/he shall require a statement indicating the Submission was originally published by Publisher, with appropriate citation. For example:
      © [Author name] [Year of publication] Dermsquared®. Originally published in Dermatology Online Journal, Dermsquared, Vail. All Rights Reserved. Used with permission.
      Author/Artist shall notify Publisher of any subsequent publication and provide a copy or URL.
    2. TERM. The term of this agreement shall be from the date of submission for the life of the copyright in Submission.
    3. Time is of the essence for delivery of the final Submission.  Should Author/Artist fail to deliver the completed Submission to Publisher’s sole satisfaction (including acceptable images where applicable) within six months of acceptance of Submission for publication, Publisher may, at its sole discretion, terminate this Agreement without any liability or obligation to Author/Artist, provided that Author/Artist may not publish the Submission elsewhere within one year of termination without first reoffering it to Publisher on the terms of that current agreement.
    4. NOTICE ADDRESS. All notices under this Agreement shall be effective on the date entered above between the Publisher (Dermsquared, Re Dermatology Online Journal, 2121 North Frontage Road West #253, Vail, CO 81657) and the Author/Artist at address provided during the registration process. Notice may also be sent electronically to Adam Rigel at arigel@hcesquared.com.
    5. GOVERNING LAW. This Agreement shall be construed and enforced in accordance with the laws of the State of Delaware without regard to conflict of laws.
    6. CONTINUATION OF OBLIGATIONS. This Agreement shall bind and shall inure to the benefit of the successors and assigns of either party.
    7. WAIVER OF RIGHTS. No delay or failure of either party in exercising any right, and no partial or single exercise of any right, shall be deemed to constitute a waiver of that right or any other right.
    8. Entire Agreement. This Agreement contains all of the understandings between the parties and may not be amended, altered or changed, except by an amendment in writing executed by both parties.

I understand these terms and conditions, and wish for Publisher to consider publication of my Submission in the Journal.

(Rev. May 2025)

Privacy Statement

Please review Dermsquared's Privacy Policy here